Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during … M Faria, MS Halquist, M Yuan, W Mylott Jr, RG Jenkins, HT Karnes Journal of Chromatography B 1001, 156-168, 2015 | 53 | 2015 |
Multiplex LC-MS/MS assays for clinical bioanalysis of MEDI4276, an antibody-drug conjugate of tubulysin analogue attached via cleavable linker to a biparatopic humanized … M Faria, M Peay, B Lam, E Ma, M Yuan, M Waldron, WR Mylott Jr, M Liang, ... Antibodies 8 (1), 11, 2019 | 43 | 2019 |
Multifaceted bioanalytical methods for the comprehensive pharmacokinetic and catabolic assessment of MEDI3726, an anti-prostate-specific membrane antigen pyrrolobenzodiazepine … Y Huang, CJ Del Nagro, K Balic, WR Mylott Jr, OA Ismaiel, E Ma, M Faria, ... Analytical Chemistry 92 (16), 11135-11144, 2020 | 16 | 2020 |
An extended stable isotope‐labeled signature peptide internal standard for tracking immunocapture of human plasma osteopontin for LC‐MS/MS quantification M Faria, MS Halquist, M Yuan, W Mylott Jr, RG Jenkins, HT Karnes Biomedical Chromatography 29 (11), 1780-1782, 2015 | 12 | 2015 |
Nanotechnology in cancer: A clinical review O Agrawal, R Brahme, M Faria, S Shidhaye Journal of Applied Pharmaceutical Science, 25-29, 2011 | 12 | 2011 |
Liquid chromatography–tandem mass spectrometry method for quantification of thymidine kinase activity in human serum by monitoring the conversion of 3′-deoxy-3 … M Faria, MS Halquist, E Kindt, W Li, HT Karnes, PJ O’Brien Journal of Chromatography B 907, 13-20, 2012 | 11 | 2012 |
Internal standards for absolute quantification of large molecules (proteins) from biological matrices by LC-MS/MS M Faria, MS Halquist Calibration Valid. Anal. Methods A Sampl. Curr. Approaches 61, 2018 | 8 | 2018 |
Immunoaffinity LC–MS/MS to quantify a PEGylated anti-Factor D Fab biotherapeutic in cynomolgus monkey serum L Liu, Y Liu, L Dai, C Stella, M Faria, J Shao, JL Hicks, DF Cortes, ... Bioanalysis 11 (23), 2161-2173, 2019 | 7 | 2019 |
Peptides and Oligonucleotide-Based Therapy: Bioanalytical Challenges and Practical Solutions R Boyanapalli, I Singh, M Faria An Introduction to Bioanalysis of Biopharmaceuticals, 131-155, 2022 | 1 | 2022 |
Quantitative mass spectrometric investigations of protein biomarkers: Serum thymidine kinase 1 and human osteopontin M Faria Virginia Commonwealth University, 2014 | 1 | 2014 |
HPLC fingerprinting of fenugreek seeds using trigonelline as a biomarker H PD, M Faria Indian Drugs 45, 12, 2008 | 1 | 2008 |
An Introduction to Bioanalysis of Antibody-Drug Conjugates M Faria, V Ramani, S Kumar An Introduction to Bioanalysis of Biopharmaceuticals, 49-74, 2022 | | 2022 |
Liquid Chromatography and Tandem Mass Spectrometry Method for the Quantitative Determination of Tanespimycin and its Active Metabolite in Human Plasma: Method Validation and … M Faria, OA Ismaiel, J Waltrip, T Mariannino, M Yuan, W Mylott, ... | | 2020 |
LC-MS/MS Method for the Quantitative Determination of Tanespimycin and its Active Metabolite in Human Plasma: Method Validation and Overcoming an Insidious APCI Source Phenomenon M Faria, OA Ismaiel, J Waltrip, T Mariannino, M Yuan, W Mylott, ... J Appl Bioanal 6 (3), 145-163, 2020 | | 2020 |
Addressing Bioanalytical Needs of Antibody-Based Biothera-peutics by LC-MS M Faria J Appl Bioanal 6 (1), 7-11, 2020 | | 2020 |
A simplified approach to measuring thymidine kinase activity in cells, tumors, and blood as a biomarker of tumor proliferative potential W Li, X Kang, KE Kindt, C Zhang, M Spilker, PJ Berlinski, M Eisenbraun, ... Cancer Research 72 (8_Supplement), 2841-2841, 2012 | | 2012 |
Quantification of Human Osteopontin, a Cancer Biomarker Protein from Plasma by Immunoaffinity and Microflow LC-MS/MS M Faria, MS Halquist, M Yuan, W Mylott Jr, RG Jenkins, HT Karnes | | |
A Simplified Approach to Measuring Thymidine Kinase Activity in Cultured Cells, Tumors, and Blood as a Biomarker of Tumor Proliferative Potential 2841 W Li, E Kindt, X Kang, P Berlinski, M Eisenbraun, M Elliott, JA Arbuckle, ... | | |
Quantitative Mass Spectrometric Evaluation of Human Osteopontin, an Inflammation Biomarker Protein Using a Biologically Relevant Tryptic Signature Peptide M Faria, MS Halquist, HT Karnes | | |